Literature DB >> 22315187

Occurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p.E139D.

Silke Pauli1, Doris Steinemann, Kai Dittmann, Jürgen Wienands, Moneef Shoukier, Marita Möschner, Peter Burfeind, Georgi Manukjan, Gudrun Göhring, Gabriele Escherich.   

Abstract

Noonan syndrome (NS) is a common autosomal dominant condition characterized by short stature, congenital heart defects, and dysmorphic facial features caused in approximately 50% of cases by missense mutations in the PTPN11 gene. NS patients are predisposed to malignancies including myeloproliferative disorders or leukemias. We report a female NS patient carrying a PTPN11 germline mutation c.417 G > C (p.E139D), who developed in her second year of life an acute lymphoblastic leukemia (ALL) and after remission, she developed at 4 years of age a juvenile myelomonocytic leukemia (JMML). Molecular genetic analysis of lymphoblastic blasts at the time of the ALL diagnosis revealed the germline mutation in a heterozygous state, while in the myelomonocytic blasts occurring with JMML diagnosis, the mutation p.E139D was found in a homozygous state due to a uniparental disomy (UPD). These findings lead to the suggestion that the pathogenesis of ALL and JMML in our patient is due to different mechanisms including somatically acquired secondary chromosomal abnormalities.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22315187     DOI: 10.1002/ajmg.a.34439

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Association of population mixing and acute lymphocytic leukemia in children and young adults.

Authors:  Joseph Lubega; M David Hallman; Philip J Lupo; Yunxin Fu; Leif Peterson; Michael E Scheurer
Journal:  Cancer Epidemiol       Date:  2020-04-28       Impact factor: 2.984

Review 2.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.